Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dorr

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Molecular Cancer Therapeutics|January 14, 2009
UA62784, a novel inhibitor of centromere protein E kinesin-like proteinMeredith C Henderson, Yeng-Jeng Y Shaw, Hong Wang, et al.
Anti-Cancer Drugs|November 1, 2006
Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in miceAlan Pourpak, Ross O Meyers, Betty K Samulitis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity studyG Tricot, D S Alberts, C Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2009
Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancerArthur Y Shaw, Meredith C Henderson, Gary Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individualsH-H Sherry Chow, Yan Cai, Iman A Hakim, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2009
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancerSteven J Cohen, Mark M Zalupski, Manuel R Modiano, et al.
Investigational New Drugs|November 27, 2012
Characterization of a membrane-active anti-tumor agent, UA8967Robert T Dorr, Betty K Samulitis, Lee Wisner, et al.
JAMA|November 20, 1991
Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropinN Levine, S N Sheftel, T Eytan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Human tumor models in the severe combined immune deficient (scid) mouseG D Paine-Murrieta, C W Taylor, R A Curtis, et al.
Nutrition and Cancer|January 1, 1996
Disposition and metabolism of topically administered alpha-tocopherol acetate: a common ingredient of commercially available sunscreens and cosmeticsD S Alberts, R Goldman, M J Xu, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Molecular Cancer Therapeutics|January 14, 2009
UA62784, a novel inhibitor of centromere protein E kinesin-like proteinMeredith C Henderson, Yeng-Jeng Y Shaw, Hong Wang, et al.
Anti-Cancer Drugs|November 1, 2006
Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in miceAlan Pourpak, Ross O Meyers, Betty K Samulitis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity studyG Tricot, D S Alberts, C Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2009
Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancerArthur Y Shaw, Meredith C Henderson, Gary Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individualsH-H Sherry Chow, Yan Cai, Iman A Hakim, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2009
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancerSteven J Cohen, Mark M Zalupski, Manuel R Modiano, et al.
Investigational New Drugs|November 27, 2012
Characterization of a membrane-active anti-tumor agent, UA8967Robert T Dorr, Betty K Samulitis, Lee Wisner, et al.
JAMA|November 20, 1991
Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropinN Levine, S N Sheftel, T Eytan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Human tumor models in the severe combined immune deficient (scid) mouseG D Paine-Murrieta, C W Taylor, R A Curtis, et al.
Nutrition and Cancer|January 1, 1996
Disposition and metabolism of topically administered alpha-tocopherol acetate: a common ingredient of commercially available sunscreens and cosmeticsD S Alberts, R Goldman, M J Xu, et al.
Pageof 19